MYGN

7:11 am Myriad Genetics publishes Prolaris data in the Journal of Urology; data shows Prolaris predicts metastases in prostate cancer from biopsies

moreView todays social media effects on MYGNView the latest stocks trending across Twitter. Click to view dashboardSee who Myriad is hiring next, click here to view […]

Myriad Genetics Publishes Prolaris(R) Data in the Journal of Urology

[GlobeNewswire] – SALT LAKE CITY — Myriad Genetics, Inc. today announced it has published data in the Journal of Urology demonstrating that its Prolaris test accurately predicted, based on biopsy specimens, which men would … moreView todays social media effects on MYGNView the latest stocks trending across Twitter. Click to view dashboardSee who Myriad is hiring next, click here to […]

Myriad Is Angling for Gene Dominance

moreView todays social media effects on MYGNView the latest stocks trending across Twitter. Click to view dashboardSee who Myriad is hiring next, click here to view […]

Myriad Genetics to Announce Third Fiscal Quarter 2013 Results on Tuesday, May 7, 2013

[at noodls] – April 18, 2013 SALT LAKE CITY, April 18, 2013 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (Nasdaq:MYGN) today announced that it will issue financial results for the third fiscal quarter 2013 following the … moreView todays social media effects on MYGNView the latest stocks trending across Twitter. Click to view dashboardSee who Myriad is hiring next, click here […]

Myriad Adopts RainDance’s Thunderstorm Platform for Next-Generation Sequencing Based Hereditary Cancer Panel

[at noodls] – SALT LAKE CITY and LEXINGTON, Mass., April 17, 2013 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (Nasdaq:MYGN) and RainDance Technologies, Inc. today announced that they have entered into a commercial agreement … moreView todays social media effects on MYGNView the latest stocks trending across Twitter. Click to view dashboardSee who Myriad is hiring next, click here to view […]

Myriad and PharmaMar Announce First Commercial Partnership With Myriad’s New HRD Test

[at noodls] – March 26, 2013 Myriad and PharmaMar Announce First Commercial Partnership With Myriad’s New HRD Test SALT LAKE CITY, March 26, 2013 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (Nasdaq:MYGN) today announced … moreView todays social media effects on MYGNView the latest stocks trending across Twitter. Click to view dashboardSee who Myriad is hiring next, click here to view […]

BRCA Testing Granted Preventive Care Designation Under the Affordable Care Act

[at noodls] – March 6, 2013 SALT LAKE CITY, March 6, 2013 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (Nasdaq:MYGN) announced today that three federal agencies including the U.S. Department of Health and Human Services, … moreView todays social media effects on MYGNView the latest stocks trending across Twitter. Click to view dashboardSee who Myriad is hiring next, click here to […]

Noridian Prices Molecular Pathology Codes; Myriad Confirms Guidance for Fiscal 2013

[at noodls] – March 1, 2013 SALT LAKE CITY, March 1, 2013 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (Nasdaq:MYGN) announced today that Noridian Administrative Services LLC (Noridian), Medicare administrative … moreView todays social media effects on MYGNView the latest stocks trending across Twitter. Click to view dashboardSee who Myriad is hiring next, click here to view […]

Myriad Genetics to Announce Second Fiscal Quarter 2013 Results on Tuesday, February 5, 2013

[at noodls] – January 15, 2013 Myriad Genetics to Announce Second Fiscal Quarter 2013 Results on Tuesday, February 5, 2013 SALT LAKE CITY, Jan. 15, 2013 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (Nasdaq:MYGN) today … moreView todays social media effects on MYGNView the latest stocks trending across Twitter. Click to view dashboardSee who Myriad is hiring next, click here to […]